Literature DB >> 32501756

Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19.

Andrea Mazzanti1,2,3, Martina Briani4, Deni Kukavica1,2, Francesca Bulian5, Stefano Marelli1, Alessandro Trancuccio1, Nicola Monteforte1, Tommaso Manciulli1,6, Massimo Morini1, Annalisa Carlucci1, Giacomo Viggiani7, Francesco Cannata4,7, Sara Negri1, Raffaella Bloise1, Mirella Memmi1, Patrick Gambelli1, Andrea Carbone1, Martina Molteni1, Raffaella Bianchini1, Rita Salgarello1, Silvia Sozzi1, Pasquale De Cata1, Francesco Fanfulla1, Piero Ceriana1, Carlo Locatelli1, Carlo Napolitano1,2,3, Luca Chiovato1,8, Luca Tomasi5, Giulio G Stefanini4,7, Gianluigi Condorelli4,7, Silvia G Priori1,2,3,9.   

Abstract

Entities:  

Keywords:  COVID-19; arrhythmia; hydroxychloroquine; long QT syndrome

Mesh：

Substances：

Year:  2020        PMID： 32501756     DOI： 10.1161/CIRCULATIONAHA.120.048476

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  12 in total

1.  The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.

Authors:  Tyler C Beck; Kyle R Beck; Calvin B Holloway; Richard A Hemings; Thomas A Dix; Russell A Norris
Journal:  Front Pharmacol       Date:  2020-08-28       Impact factor: 5.810

2.  Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.

Authors:  Andrea Cortegiani; Mariachiara Ippolito; Giulia Ingoglia; Pasquale Iozzo; Antonino Giarratano; Sharon Einav
Journal:  J Crit Care       Date:  2020-07-11       Impact factor: 3.425

3.  The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019.

Authors:  Murat Çap; Önder Bilge; Ferhat Işık; Cengiz Burak; Ali Karagöz; Ümit İnci; Abdurrahman Akyüz; Burhan Aslan; Bernas Altıntaş; Rojhat Altındağ; İlyas Kaya; Mehmet Şahin Adıyaman; Muhammed Süleymanoğlu; Şafak Kaya; Erkan Baysal
Journal:  J Electrocardiol       Date:  2020-11-06       Impact factor: 1.438

4.  Targeting Endolysosomal Two-Pore Channels to Treat Cardiovascular Disorders in the Novel COronaVIrus Disease 2019.

Authors:  Francesco Moccia; Sharon Negri; Pawan Faris; Angelica Perna; Antonio De Luca; Teresa Soda; Roberto Berra-Romani; Germano Guerra
Journal:  Front Physiol       Date:  2021-01-26       Impact factor: 4.566

5.  Electrocardiographic manifestations of COVID-19: Effect on cardiac activation and repolarization.

Authors:  Avni Thakore; James Nguyen; Simcha Pollack; Stefan Muehlbauer; Benjamin Chi; Derek Knight; Bhoomi Mehrotra; Joshua Stern; J Jane Cao; Charles Lucore; Joseph Levine
Journal:  EClinicalMedicine       Date:  2021-08-06

Review 6.  Arrhythmias in COVID-19.

Authors:  Summit Pandat; Zhihao Zhu; Stephanie Fuentes-Rojas; Paul Schurmann
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-12-15

Review 7.  Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19.

Authors:  Marco Schiavone; Alessio Gasperetti; Elisa Gherbesi; Luca Bergamaschi; Roberto Arosio; Gianfranco Mitacchione; Maurizio Viecca; Giovanni B Forleo
Journal:  Card Electrophysiol Clin       Date:  2021-10-30

8.  QTc interval prolongation, inflammation, and mortality in patients with COVID-19.

Authors:  Simone Gulletta; Paolo Della Bella; Luigi Pannone; Giulio Falasconi; Lorenzo Cianfanelli; Savino Altizio; Elena Cinel; Valentina Da Prat; Antonio Napolano; Giuseppe D'Angelo; Luigia Brugliera; Eustachio Agricola; Giovanni Landoni; Moreno Tresoldi; Patrizia Querini Rovere; Fabio Ciceri; Alberto Zangrillo; Pasquale Vergara
Journal:  J Interv Card Electrophysiol       Date:  2021-07-22       Impact factor: 1.759

9.  Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis.

Authors:  Sultan Ayoub Meo; Syed Ziauddin A Zaidi; Trisha Shang; Jennifer Y Zhang; Thamir Al-Khlaiwi; Ishfaq A Bukhari; Javed Akram; David C Klonoff
Journal:  J King Saud Univ Sci       Date:  2020-09-06

10.  Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis.

Authors:  Teodoro J Oscanoa; Xavier Vidal; Jørgen K Kanters; Roman Romero-Ortuno
Journal:  Int J Antimicrob Agents       Date:  2020-10-24       Impact factor: 15.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.